Can a Small New Stem Cell Pact Move the Needle for Celgene? – 24/7 Wall St.
24/7 Wall St. |
Can a Small New Stem Cell Pact Move the Needle for Celgene?
24/7 Wall St. Celgene Corp. (NASDAQ: CELG) is one of the world's top biotech stocks now, and its market cap is nearly $100 billion. The company has made a new investment in a stem cell company in Australia, and 24/7 Wall St. wants to know if this is the sort of … Mix Momentum At Considerable Level- Celgene Corporation (NASDAQ:CELG … |
